Susquehanna International Group, LLP Biocept Inc Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
BUY
$0.24 - $0.62 $2,479 - $6,405
10,331 Added 85.06%
22,477 $7,000
Q4 2022

Feb 14, 2023
SELL
$0.47 - $0.89 $3,557 - $6,736
-7,569 Reduced 38.39%
12,146 $6,000
Q3 2022

Nov 14, 2022
BUY
$0.75 - $1.2 $14,786 - $23,658
19,715 New
19,715 $18,000
Q4 2021

Feb 14, 2022
BUY
$3.43 - $4.22 $43,300 - $53,273
12,624 Added 79.38%
28,528 $103,000
Q3 2021

Nov 15, 2021
BUY
$3.39 - $4.34 $18,631 - $23,852
5,496 Added 52.81%
15,904 $64,000
Q2 2021

Aug 11, 2021
SELL
$4.03 - $5.07 $240,091 - $302,050
-59,576 Reduced 85.13%
10,408 $44,000
Q1 2021

May 17, 2021
BUY
$4.74 - $7.94 $331,724 - $555,672
69,984 New
69,984 $356,000

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email